Neomycin Sulfate And Polymyxin B Sulfate Gramicidin

   
Google
 
Web NewDrugInformation.com

Neomycin Sulfate And Polymyxin B Sulfate Gramicidin


Drug - Neomycin Sulfate And Polymyxin B Sulfate Gramicidin
The trade name of the product as shown on the labeling.

Dosage - SOLUTION/DROPS; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Gramicidin; Neomycin Sulfate; Polymyxin B Sulfate
Multiple ingredients are in alphabetical order.

Strength - 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML
The potency of the active ingredient(s), Gramicidin; Neomycin Sulfate; Polymyxin B Sulfate. May repeat for multiple part products.

Applicant - PHARMAFAIR
The firm name holding legal responsibility for Neomycin Sulfate And Polymyxin B Sulfate Gramicidin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062383
The FDA assigned number to Neomycin Sulfate And Polymyxin B Sulfate Gramicidin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Neomycin Sulfate And Polymyxin B Sulfate Gramicidin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 31, 1982
The date Neomycin Sulfate And Polymyxin B Sulfate Gramicidin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Neomycin Sulfate And Polymyxin B Sulfate Gramicidin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Neomycin Sulfate And Polymyxin B Sulfate Gramicidin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmafair Inc
The full name of the firm holding legal responsibility for the new application of Neomycin Sulfate And Polymyxin B Sulfate Gramicidin.

Neomycin Sulfate And Polymyxin B Sulfate Gramicidin


Neomycin Sulfate And Polymyxin B Sulfate Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic
Chorionic Gonadotropin 5,000 Units/vial Injectable; Injection
Follutein 10,000 Units/vial Injectable; Injection
Pregnyl 10,000 Units/vial Injectable; Injection
Zoladex Eq 10.8mg Base Implant; Implantation
Zoladex Eq 3.6mg Base Implant; Implantation
Neomycin And Polymyxin B Sulfates And Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic
Neomycin And Polymyxin B Sulfates And Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic
Neomycin And Polymyxin B Sulfates And Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic
Neomycin And Polymyxin B Sulfates And Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic

NewDrugInformation